Search results
Results From The WOW.Com Content Network
In May 2018, Abiomed was added to the S&P 500 index. [16] During the S&P's rise from 2000 to 3000, Abiomed was the index's top performing stock. [17] In 2018, Abiomed built a $17 million Innovation Center to facilitate research and product development at its headquarters in Danvers. [18]
Need help? Call us! 800-290-4726 Login / Join. Mail
Abiomed's (ABMD) Impella RP with SmartAssist gets the highest level of approval from the FDA for treatment of right heart failure.
Abiomed [2] Cardiac Arrhythmia Diagnosis & Treatment Products (Biosense Webster) Carto 3 System [3] Thermocool Smarttouch SF Catheter [4] Carto Vizigo Bi-Directional Guiding Sheath [5] Pentaray Nav ECO High Density Mapping Catheter [6] Neurovascular (Cerenovus) Embotrap III Revascularization Device [7] Embovac Aspiration Catheter [8]
For premium support please call: 800-290-4726 more ways to reach us
Abiomed sells other pumps under the Impella brand, which are used for different therapeutic reasons. Johnson & Johnson struck a massive $16.6 billion all-cash deal in 2022 to buy Abiomed to boost ...
Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients suffering from COVID-19 ...
Cell Signaling Technology, Inc. (CST) is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. CST maintains an in-house research program, particularly in the area of cancer research, and has published ...